Skip to main content

Paula Sowon Lee, MD

Paula Lee, MD
Assistant Professor of Obstetrics and Gynecology
Campus Mail: Box 3079 Med Ctr, Durham, NC 27710
Phone: (919) 684-3765
Email: paula.s.lee@duke.edu

Dr. Paula Lee is an Assistant Professor in the Division of Gynecologic Oncology at Duke University Medical Center.  She received her undergraduate degree in Biology and Asian Studies from the University of Michigan and graduated with a combined medical degree with a Masters in Public Health from Tulane University.  She completed her residency in Obstetrics and Gynecology and her fellowship in Gynecologic Oncology at Duke University Medical Center.  Upon completing her oncology fellowship in 2007, she accepted a faculty position within the Division of Gynecologic Oncology at Duke.

Her research interests include therapeutic and surgical trials for gynecologic malignancies and improving end of life care. She is board certified in Gynecologic Oncology and Hospice and Palliative Medicine. She has successfully mentored residents and fellows in their research and clinical endeavors. She is also involved in global health initiatives and has interests in developing a sustainable training program in gynecologic oncology in sub-saharan African countries. 

Education and Training

  • Residency, Ob/Gyn, Duke University, 2000 - 2004
  • M.D., Tulane University, 2000

Research

Research interests include therapeutic and surgical trials for gynecologic malignancies and improving end of life care.

Publications

Jewell, EL, Darcy, KM, Hutson, A, Lee, PS, Havrilesky, LJ, Grace, LA, Berchuck, A, and Secord, AA. "Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study." Gynecologic Oncology 115, no. 3 (December 2009): 424-429.

Full Text

Lee, PS, Bland, A, Valea, FA, Havrilesky, LJ, Berchuck, A, and Secord, AA. "Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program." Jsls : Journal of the Society of Laparoendoscopic Surgeons 13, no. 4 (October 2009): 467-472.

Full Text

Horne, HN, Lee, PS, Murphy, SK, Alonso, MA, Olson, JA, and Marks, JR. "Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy." Molecular Cancer Research : Mcr 7, no. 2 (February 10, 2009): 199-209.

Full Text

Matsumura, N, Huang, Z, Baba, T, Lee, PS, Barnett, JC, Mori, S, Chang, JT, Kuo, W-L, Gusberg, AH, Whitaker, RS, Gray, JW, Fujii, S, Berchuck, A, and Murphy, SK. "Yin yang 1 modulates taxane response in epithelial ovarian cancer." Molecular Cancer Research : Mcr 7, no. 2 (February 10, 2009): 210-220.

Full Text

Bland, AE, Calingaert, B, Secord, AA, Lee, PS, Valea, FA, Berchuck, A, Soper, JT, and Havrilesky, L. "Relationship between tamoxifen use and high risk endometrial cancer histologic types." Gynecol Oncol 112, no. 1 (January 2009): 150-154.

Full Text

Lee, PS, Bakelaar, R, Fitpatrick, CB, Ellestad, SC, Havrilesky, LJ, and Alvarez Secord, A. "Medical and surgical treatment of placenta percreta to optimize bladder preservation." Obstet Gynecol 112, no. 2 Pt 2 (August 2008): 421-424.

Full Text

Schildkraut, JM, Moorman, PG, Bland, AE, Halabi, S, Calingaert, B, Whitaker, R, Lee, PS, Elkins-Williams, T, Bentley, RC, Marks, JR, and Berchuck, A. "Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup." Cancer Epidemiol Biomarkers Prev 17, no. 3 (March 2008): 585-593.

Full Text

Lee, PS, Teaberry, V, Bland, AE, Huang, Z, Secord, AA, Berchuck, A, and Murphy, SK. "MAL, a gene associated with survival in epithelial ovarian cancer, is epigenetically regulated." March 2008.

Scholars@Duke

Rubatt, JM, Darcy, KM, Hutson, A, Bean, SM, Havrilesky, LJ, Lee, PS, Grace, LA, Berchuck, A, and Secord, AA. "Prognostic relevance of microvessel density in previously untreated, advanced-stage epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study." March 2008.

Scholars@Duke

Barnett, JC, Bland, A, Whitaker, R, Calingaert, B, Bentley, RC, Lee, PS, Moorman, PC, Schildkraut, JM, and Berchuck, A. "The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S125-S125.

Scholars@Duke

Pages